Triple Antibiotic Plus Pain Relief
- Product NDC
- 42507-679
- 11-digit product format
- 425070679
- Labeler code
- 42507
- Product ID
- 42507-679_a0f2663d-acb6-4828-93b4-74f3423a13ae
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bacitracin, Neomycin, Polymyxin B, Pramoxine HCl
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- HyVee Inc
- Application
- M004
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2015-09-27
- Substance
- BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE; PRAMOXINE HYDROCHLORIDE
- Active strength
- 500; 3.5; 10000; 10 [USP'U]/g; mg/g; [USP'U]/g; mg/g
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Decreased Cell Wall Synthesis & Repair [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 42507-679-64 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 42507-679-64 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 42507-679-64 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 42507-679-64 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 42507-679-64 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 42507-679-64 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 42507-679-64 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 42507-679-64 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 42507-679-64 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 42507-679-64 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 42507-679-64 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 42507-679-64 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Triple Antibiotic Plus Pain Relief
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BACITRACIN ZINC | 500 [USP'U]/g |
| NEOMYCIN SULFATE | 3.5 mg/g |
| POLYMYXIN B SULFATE | 10000 [USP'U]/g |
| PRAMOXINE HYDROCHLORIDE | 10 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 89Y4M234ES | Internal UNII lookup |
| 057Y626693 | Internal UNII lookup |
| 19371312D4 | Internal UNII lookup |
| 88AYB867L5 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1359350 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 69a4b642-b7ec-43cc-aa57-6858da0b3d63 | Available on FDA.report |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triple Antibiotic First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN AND POLYMYXIN B SULFATE | Universal Distribution Center LLC | 78f00296-267b-44c3-a9e3-c40f122e905e | 2024-05-14 | Warnings | M004 |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | JHK Inc dba American Safety & First Aid | 26e66025-9457-42b3-9319-51302c17506e | 2024-04-26 | Warnings | M004 |
| Hydrogen Peroxide | HYDROGEN PEROXIDE | JHK Inc | 1472c854-09c8-4ad8-b8a6-0235440ac26b | 2024-04-26 | Warnings | M004 |
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | JHK Inc | abae6a80-e859-47b5-8e34-d391eb854583 | 2024-04-26 | Warnings | M004 |
| Antiseptic | BENZALKONIUM CHLORIDE, BENZOCAINE | JHK Inc | 0ac5d890-c262-4a30-9fd8-2de6cb0f7601 | 2024-04-25 | Warnings | M004 |
| First Aid Antibiotic Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | M-star (Hubei) Health&Care Products Co., Ltd. | c6f2656e-b822-4d61-b557-dd2046dd51f5 | 2024-04-01 | Warnings | M004 |
| Antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE | CVS PHARMACY, INC | 32e92acf-2e48-4933-8e08-e1df650e7d19 | 2024-03-15 | Warnings | M004 |
| Major Bacitracin | BACITRACIN | Major Pharmaceuticals | 13288efb-e282-68f8-e063-6294a90ae712 | 2024-03-08 | Warnings | M004 |
| UniShield TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unishield | 00b85d3a-322b-43c1-b022-5f6ed50c6609 | 2024-03-02 | Warnings | M004 |
| Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Chain Drug Marketing Association Inc. | 1277942d-753f-ab69-e063-6394a90a496a | 2024-02-28 | Warnings | M004 |
| Triple Antibiotic with Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE | Safetec of America, Inc. | ca1df4a0-844d-4b1d-b972-f2704a8ebbab | 2024-02-16 | Warnings | M004 |
| Single Antibiotic | BACITRACIN ZINC | Safetec of America, Inc. | 9993c204-6e61-4da3-90ef-2b7dfa09c920 | 2024-02-14 | Warnings | M004 |
| Single Antibiotic with Neomycin | NEOMYCIN SULFATE | Safetec of America | e989cf7e-f3d1-42d2-af45-fc80095b97cb | 2024-02-08 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 96c41fc1-81f9-4757-abc6-867b5383ed5d | 2024-02-07 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 2c2aa8af-2adb-4f59-ac20-15818d0e28e7 | 2024-02-07 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 03c05028-5a5f-4690-a836-cc1b1044ab39 | 2024-02-05 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Safetec of America, Inc. | 59494d5c-dd8a-431c-8e6a-4e1151ba7460 | 2024-02-05 | Warnings | M004 |
| Triple Antibiotic | FIRST AID ANTIBIOTIC | BluePoint Laboratories | c47e15bd-1062-4cca-e053-2995a90a9075 | 2024-01-31 | Warnings | M004 |
| Neomycin | NEOMYCIN OINTMENT | Dynarex Corporation | 0f9e087b-6e86-a3c7-e063-6394a90ac8d4 | 2024-01-23 | Warnings | M004 |
| Antibiotic and Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Target Corporation | 050be94c-1fbb-4d84-82c6-841aac8f318e | 2024-01-18 | Warnings | M004 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42507-679-64 | 42507067964 | 1 TUBE in 1 CARTON (42507-679-64) / 28 g in 1 TUBE (42507-679-28) | 1 tube | 2015-09-27 | No | No | Current |